A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence
一项随机、双盲、安慰剂对照的I/II期临床试验,研究人乳头瘤病毒治疗性疫苗PepCan降低头颈癌复发率的疗效
期刊:
影响因子:
doi:10.64898/2026.01.09.26343801
Bivens, Emily; Atiq, Omar; Evans, Teresa; Bimali, Milan; Brown, Ginger; Crane, Jasmine; Darwish, Nadia; Faulkner, Jennifer L; Govindarajan, Rangaswamy; Johnson, Aaron; Kurilung, Alongkorn; Lazarenko, Oxana; Lu, Yong-Chen; Marsh, Keanna; Moreno, Mauricio; Nookaew, Intawat; Robeson, Michael; Sunde, Jumin; Ussery, David; Vural, Emre; Wilman, Mindy; Nakagawa, Mayumi